Detalhe da pesquisa
1.
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
Breast Cancer Res
; 25(1): 62, 2023 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37280713
2.
Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development.
Nature
; 507(7493): 513-8, 2014 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24463518
3.
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel.
Blood
; 138(12): 1081-1085, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34041526
4.
Versatile CAR T-cells for cancer immunotherapy.
Contemp Oncol (Pozn)
; 22(1A): 73-80, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29628798
5.
Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.
J Immunol
; 190(12): 6681-93, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23686488
6.
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.
Lancet Oncol
; 15(1): 69-77, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24332512
7.
Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.
Int J Cancer
; 135(12): 2834-46, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24771328
8.
TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas.
Blood
; 120(8): 1613-23, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22645177
9.
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
Res Sq
; 2023 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36824840
10.
Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas.
J Immunother Cancer
; 11(11)2023 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007239
11.
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma.
Blood Adv
; 6(4): 1143-1151, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015819
12.
Crystal structure of a bony fish beta2-microglobulin: insights into the evolutionary origin of immunoglobulin superfamily constant molecules.
J Biol Chem
; 285(29): 22505-12, 2010 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20444690
13.
The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes.
J Infect Dis
; 202(8): 1171-80, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20831383
14.
Crystallization and preliminary X-ray analysis of the V domain of human nectin-2.
Acta Crystallogr Sect F Struct Biol Cryst Commun
; 65(Pt 6): 615-7, 2009 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19478445
15.
CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity.
Leukemia
; 33(11): 2640-2653, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028278
16.
Immunological evaluation of Lactobacillus casei Zhang: a newly isolated strain from koumiss in Inner Mongolia, China.
BMC Immunol
; 9: 68, 2008 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-19019236
17.
Expression, purification, crystallization and preliminary X-ray diffraction analysis of grass carp beta2-microglobulin.
Acta Crystallogr Sect F Struct Biol Cryst Commun
; 64(Pt 3): 200-2, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18323608
18.
Crystallization and preliminary crystallographic analysis of recombinant immunoglobulin G-binding protein from Streptococcus suis.
Acta Crystallogr Sect F Struct Biol Cryst Commun
; 64(Pt 8): 757-9, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18678951
19.
Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease.
Oncotarget
; 8(23): 38008-38021, 2017 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28402942
20.
Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.
Sci Signal
; 9(447): ra94, 2016 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27678219